Catalog No.
YHH33501
Expression system
E. coli
Species
Homo sapiens (Human)
Protein length
Gly30-Tyr149
Predicted molecular weight
16.06 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
Q16653
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
MOG, Myelin-oligodendrocyte glycoprotein
A reliable western blot workflow with improved dynamic range for the detection of myelin proteins in murine brain., PMID:40513130
DAGLA autoantibody experience at Mayo Clinic., PMID:40512252
Relapsing anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder diagnosed double positive for anti-myelin oligodendrocyte glycoprotein antibody., PMID:40506104
Clinical Features of Children With MOG-IgG Who Fulfill Criteria of Multiple Sclerosis and Overlapping Disorders., PMID:40505071
The impact of autoimmune comorbidities on the onset attack recovery in adults with AQP4-NMOSD and MOGAD., PMID:40495001
Comorbidities Are Associated With Unfavorable Outcome in Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Exploratory Study From the CROCTINO Cohort., PMID:40485599
Acute bilateral optic/chiasm neuritis with longitudinally extensive transverse myelitis and positive anti-ganglioside antibodies following mycoplasma pneumoniae pneumonia: a case report and literature review., PMID:40471512
HMGB1 Mediates Microglia-Astrocyte/Neuron Crosstalk and Pyroptosis by the TLR4/NF-κB Pathway in Multiple Sclerosis., PMID:40464519
Translational insights from EAE models : decoding MOGAD pathogenesis and therapeutic innovation., PMID:40463369
Brd4 expression in CD4 T cells and in microglia promotes neuroinflammation in experimental autoimmune encephalomyelitis., PMID:40457355
From checkboxes to emojis: a novel approach to patient-reported outcomes in multiple sclerosis., PMID:40447786
Rituximab Use for Relapse Prevention in Anti-NMDAR Antibody-Mediated Encephalitis: A Multicenter Cohort Study., PMID:40446185
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study., PMID:40442445
ATG5 controls CD80 expression in B cells and shapes cognate CD4+ T cell responses., PMID:40426021
ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1., PMID:40391649
Tyrosine kinase inhibitor, masitinib, limits neuronal damage, as measured by serum neurofilament light chain concentration in a model of neuroimmune-driven neurodegenerative disease., PMID:40367050
Seronegative Autoimmune Encephalomyelitis with Area Postrema Symptoms., PMID:40336575
CD4-Positive T-Cell Responses to MOG Peptides in MOG Antibody-Associated Disease., PMID:40332104
Clinical Features and Factors Associated With Outcome in Late Adult-Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease., PMID:40324120
An expanded polyglutamine in ATAXIN1 results in a loss-of-function that exacerbates severity of Multiple Sclerosis in an EAE mouse model., PMID:40321775
The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigm., PMID:40308584
An expanded polyglutamine in ATAXIN1 results in a loss-of-function that exacerbates severity of Multiple Sclerosis in an EAE mouse model., PMID:40307815
Utility of spinal cord axial-T2 sequence in a population-based cohort of multiple sclerosis., PMID:40301133
Assessing fall risk in multiple sclerosis using patient-reported outcomes and wearable gait metrics., PMID:40292035
Multimodal prognostication of autoimmune encephalitis: an Australian autoimmune encephalitis consortium study., PMID:40281286
Immune-related biomarkers in the neuromyelitis optica spectrum disorder; pathogenesis and therapeutic approaches., PMID:40274184
T cells in ARAP-deficient mice present defective T cell receptor signaling and reduced severity in an experimentally-induced autoimmune disease., PMID:40264755
Clinical utility of complete blood count indices in pediatric MOG antibody-associated disease., PMID:40253903
Broxyquinoline targets NLRP3 to inhibit inflammasome activation and alleviate NLRP3-associated inflammatory diseases., PMID:40253767
Research on the effects of different sugar substitutes-Mogroside V, Stevioside, Sucralose, and Erythritol-On glucose, lipid, and protein metabolism in type 2 diabetic mice., PMID:40253141
Sleep-related hypermotor epilepsy in a patient with myelin-oligodendrocyte-glycoprotein antibody disease., PMID:40234072
The utility of serum neurofilament light chain in MOGAD: Current insights and future directions., PMID:40220725
MOG35 - 55-induced EAE model of optic nerve inflammation compared to MS, MOGAD and NMOSD related subtypes of human optic neuritis., PMID:40197321
Senescent cell reduction does not improve recovery in mice under experimental autoimmune encephalomyelitis (EAE) induced demyelination., PMID:40197319
MOGAD optic neuritis after mild head/orbital trauma in six children., PMID:40187047
DNAJC30 Mutation in a Patient with Coexisting Leber's Hereditary Optic Neuropathy and Multiple Sclerosis (Harding's Syndrome): A Case Report., PMID:40182509
Myelin oligodendrocyte glycoprotein antibody-associated meningoencephalitis without cerebral parenchyma involvement on MRI: A single-centre paediatric cohort study., PMID:40172698
Study of sleep abnormalities in patients with NMOSD-MOG related disorders., PMID:40168936
Ursolic acid derivatives improved clinical signs of experimental autoimmune encephalomyelitis by modulating central nervous system inflammation., PMID:40167825
Clinico-investigational profile, relapse predictors and outcomes of pediatric patients with anti-myelin oligodendrocyte associated disorders: An experience from tertiary centre., PMID:40157037
MOG antibody non-P42 epitope is associated with a higher risk of relapse in paediatric MOGAD., PMID:40155000
Inhibition of STAT1 alleviates oxidative damage in retinal pigment epithelial cells and exhibits neuroprotective effects in autoimmune optic neuritis by upregulating IFI30 lysosomal thiol reductase., PMID:40152123
Neuroglia in autoimmune encephalitis., PMID:40148042
Evaluating the Clinical Characteristics and Ophthalmic Manifestations in Children and Adolescents with Acquired Demyelinating Disorders in China., PMID:40135307
Co-administration of Naringin and NLRP3 Inhibitor Improves Myelin Repair and Mitigates Oxidative Stress in Cuprizone-Induced Demyelination Model., PMID:40123459
Magnetic resonance imaging characteristics of myelin oligodendrocyte glycoprotein antibody positive patients -validation of current diagnostic criteria., PMID:40121699
Distinguishing Neuromyelitis Optica Spectrum Disorders Subtypes: A Study on AQP4 and C3d Epitope Expression in Cytokine-Primed Human Astrocytes., PMID:40103346
The nomogram model predicts relapse risk in myelin oligodendrocyte glycoprotein antibody-associated disease: a single-center study., PMID:40098969
Limited early IVIG for the treatment of pediatric myelin oligodendrocyte glycoprotein antibody-associated disease., PMID:40088722
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): Insights into pathogenesis and biomarkers of prognosis., PMID:40088708
For research use only. Not for human or drug use.
